Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
|
A Post Marketing Surveillance on Piqray in Korea |
Breast Cancer | South Korea | NCT05293470 | |
|
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN |
IC-MPGN | Phase3 |
Argentina Brazil Canada Czechia France Germany India Israel Italy Japan Poland Spain Switzerland Taiwan Turkey (Türkiye) United Kingdom United States Vietnam View All
|
NCT05755386 |
|
A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission |
Non-radiographic Axial Spondyloarthritis | Phase4 |
Belgium Brazil Colombia Czechia France Germany Hungary Israel Italy Malaysia Mexico Netherlands Philippines Poland Romania Thailand Turkey (Türkiye) Vietnam View All
|
NCT05622708 |
|
The Belgian REAL (BE.REAL) Registry |
Atherosclerotic Cardiovascular Disease | Belgium | NCT05726838 | |
|
A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy |
Achilles Tendinopathy | Phase2 |
France Germany United States |
NCT05592990 |
|
Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS) |
Atypical Hemolytic Uremic Syndrome | Phase3 |
China France Germany Italy Japan Spain Turkey (Türkiye) United Kingdom View All
|
NCT05935215 |
|
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. |
Lymphatic Malformations | Phase2, Phase3 |
Australia Belgium France Germany Italy Spain United States View All
|
NCT05948943 |
|
A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines |
Chronic Inducible Urticaria | Phase3 |
Argentina Australia Brazil Canada France India Italy Japan Singapore Slovakia Spain Turkey (Türkiye) United States Vietnam View All
|
NCT05976243 |
|
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia |
Myeloid Leukemia, Philadelphia Positive | Phase1, Phase2 |
China France Germany Greece Hungary Italy Japan Netherlands Poland Russia South Korea Thailand Turkey (Türkiye) United States View All
|
NCT04925479 |
|
Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study |
Relapsing Multiple Sclerosis | Portugal | NCT05809986 |